News and updates

Molekularbiologische Krebs-Diagnostik - oncgnostics auf der MEDICA

Two tests for cervical cancer with different objectives in cervical cancer screening Liquid biopsy for rapid and gentle diagnosis of head and neck tumours Current studies: GynTect DNA methylation test […]

2023 PM Oncgnostics Investment

Jena, September 05, 2023. The Hong Kong-based company Grande Bio-tech Co. Ltd. is making a seven-digit Euros investment in the Jena-based diagnostic company Oncgnostics GmbH. Oncgnostics has developed the cancer […]

Prof. Dr Harald zur Hausen died on 28 May 2023. With his research, he laid the foundation for a new way of cancer prevention. We at oncgnostics commemorate the internationally […]

Close the care gap – that is the slogan of this year’s World Cancer Day on 4th of February. Cancer can be prevented and lives saved through screening. Preventive measures […]

Schriftzug: World Health Organization (

The WHO’s cervical cancer strategy has been in place since 2020, when the World Health Organization highlighted that cervical cancer still is the fourth most common cancer in women worldwide. […]

Test auf Gebärmutterhalskrebs durch Studie bestätigt

Independent study in cervical cancer screening: The GynTect test for cervical cancer screening is highly informative regarding whether cervical cancer is present or likely to develop. In addition, GynTect is […]

The team of oncgnostics

oncgnostics at Medica 2022: Cervical cancer screening test conquers China Establishing early detection of head and neck tumours First study results for screening test for vulva and vaginal cancer At […]

Welttag der sexuellen Gesundheit. Bild: melitas

There are many more aspects to the topic of sexual health than are apparent at first glance. We want to use World Sexual Health Day as an opportunity to draw […]

GynTect receives approval in China Jena, August 25, 2022 – The cervical cancer screening test GynTect is now available to physicians and patients in China, the world’s most populous country. […]

Symbolbild: Frauengesundheit, Vulva- und Vaginalkrebs

There is still no targeted method for early detection of vulvar and vaginal cancer. This is despite the fact that an estimated 45,240 women worldwide were diagnosed with vulvar cancer […]